 | • レポートコード：QAF27613 • 出版社/出版日：QYResearch / 2021年4月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場について種類別（5-HT3阻害剤、NK1阻害剤、その他）、用途別（高催吐性化学療法、中等度催吐性化学療法、低催吐性化学療法、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・化学療法誘発性悪心・嘔吐（CINV）治療薬市場の概要 ・世界の主要地域別化学療法誘発性悪心・嘔吐（CINV）治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場規模2016-2021：種類別（5-HT3阻害剤、NK1阻害剤、その他） ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場予測2012-2027：種類別（5-HT3阻害剤、NK1阻害剤、その他） ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場規模2016-2021：用途別（高催吐性化学療法、中等度催吐性化学療法、低催吐性化学療法、その他） ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場予測2012-2027：用途別（高催吐性化学療法、中等度催吐性化学療法、低催吐性化学療法、その他） ・化学療法誘発性悪心・嘔吐（CINV）治療薬のアメリカ市場規模と予測2016-2021 ・化学療法誘発性悪心・嘔吐（CINV）治療薬のヨーロッパ市場規模と予測2016-2021 ・化学療法誘発性悪心・嘔吐（CINV）治療薬の中国市場規模と予測2016-2021 ・化学療法誘発性悪心・嘔吐（CINV）治療薬の日本市場規模と予測2016-2021 ・化学療法誘発性悪心・嘔吐（CINV）治療薬の東南アジア市場規模と予測2016-2021 ・化学療法誘発性悪心・嘔吐（CINV）治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Eisai、Mundipharma、Qilu Pharma、Teva、Novartis、Heron Therapeutics、Roche、Mylan、Tesaro） ・化学療法誘発性悪心・嘔吐（CINV）治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・化学療法誘発性悪心・嘔吐（CINV）治療薬の市場動向・機会・課題 ・調査の結論 |
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.
The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%.
Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market was valued at US$ 93 in 2020 and will reach US$ 132.5 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Scope and Market Size
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Other
Segment by Application
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Overview
1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Scope
1.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type
1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Other
1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application
1.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Highly Emetogenic Chemotherapy
1.3.3 Moderately Emetogenic Chemotherapy
1.3.4 Low Emetogenic Chemotherapy
1.3.5 Other
1.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Trends (2016-2027)
2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Forecasts by Region
2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Projections (2016-2027)
2.4.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Projections (2016-2027)
2.4.6 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Estimates and Projections (2016-2027)
3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Competition Landscape by Players
3.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players by Sales (2016-2021)
3.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players by Revenue (2016-2021)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs as of 2020)
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2016-2021)
4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Type (2022-2027)
5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2016-2021)
5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Application (2022-2027)
6 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures
6.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company
6.1.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2016-2021)
6.1.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021)
6.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type
6.2.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application
6.3.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application (2022-2027)
7 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures
7.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2016-2021)
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021)
7.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type
7.2.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures
8.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company
8.1.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2016-2021)
8.1.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021)
8.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type
8.2.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2022-2027)
8.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application
8.3.1 China 240 Sales Breakdown by Application (2016-2021)
8.3.2 China 240 Sales Breakdown by Application (2022-2027)
9 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures
9.1 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company
9.1.1 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2016-2021)
9.1.2 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021)
9.2 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type
9.2.1 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures
10.1 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company
10.1.1 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures
11.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company
11.1.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2016-2021)
11.1.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021)
11.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type
11.2.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Type (2022-2027)
11.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application
11.3.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.1.5 Merck Recent Development
12.2 Eisai
12.2.1 Eisai Corporation Information
12.2.2 Eisai Business Overview
12.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.2.5 Eisai Recent Development
12.3 Mundipharma
12.3.1 Mundipharma Corporation Information
12.3.2 Mundipharma Business Overview
12.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.3.5 Mundipharma Recent Development
12.4 Qilu Pharma
12.4.1 Qilu Pharma Corporation Information
12.4.2 Qilu Pharma Business Overview
12.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.4.5 Qilu Pharma Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.5.5 Teva Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Heron Therapeutics
12.7.1 Heron Therapeutics Corporation Information
12.7.2 Heron Therapeutics Business Overview
12.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.7.5 Heron Therapeutics Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Business Overview
12.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.8.5 Roche Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Business Overview
12.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.9.5 Mylan Recent Development
12.10 Tesaro
12.10.1 Tesaro Corporation Information
12.10.2 Tesaro Business Overview
12.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.10.5 Tesaro Recent Development
13 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Cost Analysis
13.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
13.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List
14.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
15 Market Dynamics
15.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Trends
15.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Drivers
15.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
15.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Region (2016-2021)
Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Company (2016-2021)
Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Company (2016-2021)
Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs as of 2020)
Table 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2016-2021)
Table 23. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2022-2027)
Table 26. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2022-2027)
Table 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2016-2021)
Table 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2022-2027)
Table 35. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2022-2027)
Table 37. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2022-2027)
Table 62. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2016-2021)
Table 64. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 68. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2022-2027)
Table 70. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 72. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2022-2027)
Table 98. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2016-2021)
Table 100. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 104. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2022-2027)
Table 106. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 108. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 114. Merck Recent Development
Table 115. Eisai Corporation Information
Table 116. Eisai Description and Business Overview
Table 117. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 119. Eisai Recent Development
Table 120. Mundipharma Corporation Information
Table 121. Mundipharma Description and Business Overview
Table 122. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 124. Mundipharma Recent Development
Table 125. Qilu Pharma Corporation Information
Table 126. Qilu Pharma Description and Business Overview
Table 127. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 129. Qilu Pharma Recent Development
Table 130. Teva Corporation Information
Table 131. Teva Description and Business Overview
Table 132. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 134. Teva Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 139. Novartis Recent Development
Table 140. Heron Therapeutics Corporation Information
Table 141. Heron Therapeutics Description and Business Overview
Table 142. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 144. Heron Therapeutics Recent Development
Table 145. Roche Corporation Information
Table 146. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Roche Description and Business Overview
Table 148. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 149. Roche Recent Development
Table 150. Mylan Corporation Information
Table 151. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Mylan Description and Business Overview
Table 153. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 154. Mylan Recent Development
Table 155. Tesaro Corporation Information
Table 156. Tesaro Description and Business Overview
Table 157. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 159. Tesaro Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List
Table 163. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers List
Table 164. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Trends
Table 165. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
Table 166. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
Table 167. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Picture
Figure 2. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Highly Emetogenic Chemotherapy Examples
Figure 7. Moderately Emetogenic Chemotherapy Examples
Figure 8. Low Emetogenic Chemotherapy Examples
Figure 9. Other Examples
Figure 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players Market Share by Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs: 2016 & 2020
Figure 29. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2016-2021)
Figure 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2016-2021)
Figure 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 35. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 36. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 37. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 38. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 39. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 40. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 41. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 42. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 43. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 44. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 45. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 48. Manufacturing Process Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 49. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
化学療法による吐き気および嘔吐（CINV）薬のグローバル市場調査 2019年 The global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs volume and value at global le…- 世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年） Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal c…
- 吐き気及び嘔吐治療のグローバル市場：規模・現状・予測2019-2025 Nausea and vomiting are not diseases, but rather are symptoms of many different conditions, such as infection ("stomach flu"), food poisoning, motion sickness, overeating, blocked intestine, illness, concussion or brain injury, appendicitis and migraines. Nausea and vomiting can sometimes be symptom…
- 吐き気及び嘔吐治療のグローバル市場：規模・現状・予測2019-2025 Nausea and vomiting are not diseases, but rather are symptoms of many different conditions, such as infection ("stomach flu"), food poisoning, motion sickness, overeating, blocked intestine, illness, concussion or brain injury, appendicitis and migraines. Nausea and vomiting can sometimes be symptom…
- 世界の化学療法による悪心＆嘔吐治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chemotheraphy-induced Nausea and Vomitting Treatment Market The global Chemotheraphy-induced Nausea and Vomitting Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-sta…